Abstract

Early detection of disseminating vancomycin-resistant Enterococcus faecium (VREfm) in ICU wards is crucial for outbreak identification and the implementation of prompt infection control measures. Genotypic methods like pulsed-field gel electrophoresis (PFGE) and whole-genome sequencing (WGS) are costly and time-consuming, hindering rapid response due to batch dependency. Fourier-transform infrared spectroscopy (FT-IR) offers the potential for real-time outbreak detection and reliable strain typing. We utilized FT-IR to identify clonal VREfm dissemination and compared its performance to PFGE and WGS. Between February through October 2023, an unusually high number of VREfm were recovered at a tertiary hospital in Barcelona. Isolates were examined for antimicrobial susceptibility, carriage of vanA/vanB genes and clonality was also studied using FT-IR, PFGE, and WGS. Routine FT-IR inspections revealed recurring VREfm clustering during the outbreak's initial weeks. In total, 104 isolates were recovered from 75 patients and from multiple wards. However, only one isolate was recovered from an environmental sample, suggesting the absence of environmental reservoirs. An ST80 vancomycin-resistant (vanA) E. faecium strain was the main strain responsible for the outbreak, although a few additional VREfm strains were also identified, all belonging to CC17. PFGE and cgMLST (WGS) yielded identical clustering results to FT-IR, and WGS confirmed vanA/vanB gene carriage in all VREfm isolates. Infection control measures led to a rapid decline in VREfm isolates, with no isolates detected in November. FT-IR spectroscopy offers rapid turnaround times, sensitivity, and reproducibility, comparable to standard typing methods. It proved as an effective tool for monitoring VREfm dissemination and early outbreak detection.

Details

Title
Early identification of the nosocomial spread of vancomycin-resistant Enterococcus faecium by Fourier-transform infrared spectroscopy and performance comparison with PFGE and WGS
Author
Pitart, Cristina 1   VIAFID ORCID Logo  ; Piquet, Maria 1 ; Burgwinkel, Tessa 2 ; Rocío Arazo Del Pino 2 ; Rubio, Marc 3   VIAFID ORCID Logo  ; Aguilar, Mireia 1 ; Sergi De Gea 1 ; Pulgarín, Andrea 1 ; Campo, Irene 1 ; Torralbo, Blanca 4 ; Parejo, Romina 4 ; Valls, Silvia 4 ; Fortes, Isabel 4 ; Santana, Gemina 4 ; Rubio, Elisa 5   VIAFID ORCID Logo  ; Vilella, Anna 4 ; Ana Del Río 6 ; Martínez, José Antonio 6 ; Miró, Elisenda 7   VIAFID ORCID Logo  ; Navarro, Ferran 7   VIAFID ORCID Logo  ; Mateu Espasa 1   VIAFID ORCID Logo  ; Casals-Pascual, Climent 8   VIAFID ORCID Logo  ; Vila, Jordi 8   VIAFID ORCID Logo  ; Higgins, Paul G 2   VIAFID ORCID Logo  ; Roca, Ignasi 8   VIAFID ORCID Logo 

 Department of Microbiology, Biomedical Diagnostic Center (CDB) and ISGlobal, Hospital Clínic – Universitat de Barcelona, Barcelona, Spain 
 Institute for Medical Microbiology, Immunology and Hygiene, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; German Center for Infection Research, Partner site Bonn–Cologne, Cologne, Germany 
 Department of Microbiology, Institut d’Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain 
 Department of Preventive Medicine and Epidemiology, Hospital Clínic–Universitat de Barcelona, Barcelona, Spain 
 Department of Microbiology, Biomedical Diagnostic Center (CDB) and ISGlobal, Hospital Clínic – Universitat de Barcelona, Barcelona, Spain; Molecular Core Facility, Hospital Clínic of Barcelona, Barcelona, Spain 
 Department of Infectious Diseases, Hospital Clínic–IDIBAPS, Universitat de Barcelona, Barcelona, Spain 
 Department of Microbiology, Institut d’Investigació Biomèdica Sant Pau, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain 
 Department of Microbiology, Biomedical Diagnostic Center (CDB) and ISGlobal, Hospital Clínic – Universitat de Barcelona, Barcelona, Spain; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain 
Publication year
2024
Publication date
Dec 2024
Publisher
Taylor & Francis Ltd.
e-ISSN
22221751
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3142112398
Copyright
© 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.